-

DeciBio Spins off Technology Products as a Subsidiary Entity, DeciBio Analytics

LOS ANGELES--(BUSINESS WIRE)--Last year, DeciBio Consulting announced the formation of DeciBio Analytics, a subsidiary entity that develops market intelligence informatics tools and technologies and informatics-oriented consulting work. With the mission to accelerate commercialization of innovation in the precision medicine space by building novel and propriety solutions that empower our clients, DeciBio Analytics will continue to develop both open platforms and proprietary tools that enable clients to better harness and analyze the wealth of information continuously generated about the precision medicine industry.

A wholly-owned subsidiary of DeciBio Consulting, DeciBio Analytics is led by Pranay Madan, who initiated the entity’s original efforts and is responsible for developing and executing DeciBio Analytics’ product strategy. Pranay Madan received a bachelor’s in Bio-technology Engineering from Panjab University and a master’s in Business & Science from Keck Graduate Institute. He joined DeciBio in 2014 and has since deployed multiple advanced analytical platforms across major Life Science and Healthcare clients. More information about DeciBio Analytics can be found at its website: https://www.decibio-analytics.com/

About DeciBio

DeciBio Consulting is a boutique strategy consulting and market research firm focusing on the life science industry. DeciBio's mission is to provide the market intelligence and strategic insights that drive disruption and innovation in precision medicine.

Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 healthcare corporations. DeciBio addresses business solutions in the areas of market landscape analysis, product development, voice-of-customer feedback, new product launches, technology assessment, competitive landscape analysis, business case strategy, and commercial due diligence.

Contacts

DeciBio Analytics
Jessica Lee
jessica.lee@decibio.com
310.451.4510

Industry:

DeciBio Consulting

Release Summary
Precision medicine consulting firm, DeciBio Consulting, spins off its data intelligence and software division as a subsidiary, DeciBio Analytics.
Release Versions
English
Hashtags
#bigdata
#dataanalytics
#decibio
#keckgrad
#kgi
#marketintelligence
#newco
#panjabuniversity
#precisionmedicine
#spinoff
#teamkgi

Contacts

DeciBio Analytics
Jessica Lee
jessica.lee@decibio.com
310.451.4510

Social Media Profiles
DeciBio Consulting on Facebook
DeciBio Consulting on Instagram
More News From DeciBio Consulting

Worldwide Digital & Computational Pathology Market Forecasted to Grow at 12% p.a., Reaching $2.1B by 2031 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC’s latest market report, “Digital & Computational Pathology Market Report 2026-2031,” states that the global digital pathology market, driven by an influx of open platforms that resolve interoperability challenges and standalone regulatory clearances that enable greater clinical adoption, is predicted to reach $2.1B by 2031. The third edition of DeciBio’s digital and computational pathology (D&CP) report takes a comprehensive look at t...

Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 27% p.a., Reaching ~$17B by 2031 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting has released the fourth edition of its Oncology Liquid Biopsy Market Report, offering updated global estimates of how liquid biopsy technologies are being applied across clinical and pharmaceutical research settings. The report draws on in-depth interviews with more than 30 experts in the field, including medical oncologists, biopharma researchers, technology providers, and other key healthcare stakeholders to capture the dynamic and evolving liq...

Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets – Data Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe’s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a cross-market view of current priorities, barriers, and areas of momentum. The Europe Oncology Genomics Tracker char...
Back to Newsroom